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Summary
Objectives: The study aimed to assess outcome, including level of disability, following Japanese
encephalitis (JE) in children in Indonesia.
Methods: A cohort of children diagnosed with laboratory-confirmed JE from January 2005 to
August 2006 was followed-up, with disability measured at least 4 months after discharge from
hospital. An assessment tool that can be used to rapidly determine practical level of disability and
the likelihood that a child will be able to live independently after illness, the Liverpool Outcome
Score, was used.
Results: Of 72 children with JE, determination of outcome was possible for 65 (90%). Sixteen died
in hospital or before follow-up assessment (25%). Sixteen children (25%) had severe sequelae,
indicating their function was impaired enough to likely make them dependent. Five (7%) had
moderate sequelae and 12 (18%) had minor sequelae. The remaining 16 children (25%) were
considered to have recovered fully.
* Corresponding author. Tel.: +1 206 285 3500; fax: +1 206 285 6619.
E-mail address: susanlhills@hotmail.com (S.L. Hills).
1201-9712/$36.00 # 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.ijid.2009.01.009
Conclusions: Half of the children with JE either died or were left with serious disabilities likely to
impair their ability to lead independent lives, demonstrating the severe impact of JE. Immuniza-
tion can effectively prevent JE, and an immunization program could avert some of the economic
and social burden of JE disease in Indonesia.
# 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
e390 M.S. Maha et al.Table 1 Items assessed with the Liverpool Outcome Score
Questions to the parent or caregiver
Speech and communication skills
Feeding ability
Whether the child can be left alone without coming to harm
Changes in behavior
Recognition of people other than main caregiver
Performance at school,work, or in routine activities at home
Occurrence of seizures
Dressing ability
Bladder and bowel control
Hearing
Observations of the child
Sitting
Standing up
Walking
Putting hands on head
Picking up an object (pincer grip)Introduction
Japanese encephalitis (JE) is a mosquito-borne disease and
the leading cause of viral encephalitis in Asia. Children bear
the greatest burden of JE disease, as most adults have
developed immunity to infection. In Indonesia, surveillance
studies have recently confirmed JE to be an endemic human
disease across the country.1,2
The impact of JE results from the acute hospitalization —
which is often lengthy — as well as from death and long-term
sequelae of disease. A fatal outcome occurs in about 10—30%
of patients.3—5 Disability rates of up to 50% are commonly
reported, and rates of 70% or higher have been documen-
ted.6—8 Disability in a household member has a significant
impact on the family, and the economic burden of disability is
well recognized.9,10
A simple assessment tool to measure the extent of dis-
ability after JE has recently been developed and validated.11
The Liverpool Outcome Score (available at http://www.li-
v.ac.uk/braininfections) enables a rapid appraisal of the
practical level of disability. A key purpose of the tool is to
predict the likelihood that a child will be able to live inde-
pendently. It is suitable for use by a range of health profes-
sionals, requires minimum training, and does not require any
equipment for implementation; thus, it is suitable for use in
developing country settings where specialized equipment is
not always readily available.
Sequelae at hospital discharge have been reported by
clinicians in 31—37% of Indonesian children after JE disease,
and death reported in 10—16%.1,2 There is little information
on the extent of disabilities, and no published literature on
subsequent follow-up of children after discharge, so no
information on persistence of sequelae or death post-dis-
charge is available. Assessment of disability at least 3—6
months after hospital discharge has been shown to predict
long-term status.12 This study was carried out to assess out-
come of illness and extent of disability at least 4 months
following JE disease in children in Indonesia.
Methods
Setting and subjects
This study was conducted as part of a larger study in Indonesia
from 2005 to 2006, in which surveillance for JE in children
aged 15 years and under was carried out in 15 hospitals in six
provinces (West Sumatera, West Kalimantan, East Java, West
Nusa Tenggara, East Nusa Tenggara, and Papua). Details of
the surveillance study have been published previously.1
Briefly, all children with acute encephalitis syndrome —
defined as an acute febrile illness with a change in mental
status and/or new onset of seizures (excluding simple febrile
seizures) — or who presented with acute flaccid paralysis,
were recruited as part of the surveillance study. Those withJE virus-specific immunoglobulin M (IgM) antibody in cere-
brospinal fluid or serum, detected by an IgM antibody capture
enzyme-linked immunosorbent assay, were considered
laboratory-confirmed JE cases.13
The disability assessment included all children with
laboratory-confirmed JE diagnosed between January 1,
2005 and August 31, 2006. The outcome assessments were
conducted between December 2006 and March 2007, a mini-
mum of 4 months after patient discharge.
Assessment tool
The Liverpool Outcome Score assesses basic motor and self-
care skills, as well as simple cognitive and behavioral func-
tions, through a series of 10 questions posed to the parent or
caregiver, and five observations of the child performing
simple activities. A list of all items assessed is presented
in Table 1. For many questions, the interviewee is asked to
compare the child’s ability with his or her peers of similar age
in the community.
The child receives a score for each question based on the
grading scale for that question. The final outcome score for
each child is the lowest score received for any question. Scores
range from 5 (full recovery) to 2 (severe sequelae likely to
make child dependent), with a score of 1 being death. The
interpretation of each outcome score is given in Table 2.
Conduct of assessment
The Liverpool Outcome Score was translated into Bahasa
(Indonesian language) and pre-tested before use. Health
professionals (physicians, nurses, or public health officers)
in each study province were trained on the tool’s use, either
Table 3 Characteristics of cases and details of the disability
assessments (N = 49)
Characteristic Result
Mean age (range) 5 years (1—14)
Sex 29/49 male (59%)
Mean time interval between hospital
discharge and follow-up assessment
(range)
13 months (4—24)
Province (number of cases assessed)
East Java 4
East Nusa Tenggara 5
Papua 2
West Kalimantan 16
West Nusa Tenggara 20
West Sumatera 2
Mean number of days of hospitalization
with JE during acute illness (range)
13 days (1—39)
Parent or caregiver interviewed
Mother 19
Mother and father 17
Father 7
Another relative 4
Other caregiver 1
Unknown 1
Health professional who conducted the assessment
Nurse 24
Pediatrician 14
General doctor 1
Public health officer 8
Not documented 2
JE, Japanese encephalitis.
Table 2 Interpretation of the final Liverpool Outcome Score
ScoreInterpretation
5 Full recovery
4 Minor sequelae with no effect or only minor effect
on physical function, or personality change, or on
medication
3 Moderate sequelae mildly affecting function, probably
compatible with independent living
2 Severe sequelae, impairing function sufficient to make
patient dependent
1 Death
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through explanations to individual staff members during
routine monitoring visits (training presentation available at
http://www.path.org/vaccineresources/details.php?i=678).
An implementation manual was also provided.
The majority of follow-up assessments were conducted at
the patients’ homes. In cases when it was more convenient
for the patient or assessor, the patient attended hospital for
assessment.
A similar assessment using a modified version of the Liver-
pool Outcome Score was conducted at discharge from hospi-
tal, but data were only available for a small subset of study
patients. This was part of the larger surveillance study but
was only initiated in April 2006, and implementation was
delayed in several hospitals. For this subset, it was possible to
compare the follow-up study assessments to the earlier ones
conducted at discharge.
Data analysis
Data forms from the six provinces were sent to the National
Institute of Health Research and Development (NIHRD) and
PATH in Jakarta for data entry and analysis. Data were entered
into an Epi Info database (version 6.04d, Centers for Disease
Control and Prevention, USA) and analyzed using both Epi Info
and SPSS 11.0 (SPSS Inc., Chicago, IL, USA). Differences
between proportions were tested using a two-sided Fisher’s
exact test. A p value of<0.05 was considered significant and a
p-value of <0.1 marginally statistically significant.
Ethics
Informed consent was obtained from the parent or legal
guardian of each child. Ethics approval for the assessments
was obtained from the NIHRD Committee on Health Research
Ethics, Indonesia, and PATH’s Human Subjects Protection
Committee, USA.
Results
Seventy-two children had laboratory-confirmed JE between
January 1, 2005, and August 31, 2006. Eleven children died in
hospital. Of the 61 children alive at discharge, seven children
could not be followed up andwere excluded: five families had
relocated, one village could not be visited because of secur-
ity issues, and one parent refused consent.
Five children died before follow-up. Specific details could
not be ascertained, but at least four died at home, and forthree it was confirmed to be within 5 months of discharge.
Therefore, of the 65 children for whom outcome could be
determined (90% of all cases), a total of 16 deaths occurred
(25%).
Information on cases assessed for disability
Forty-nine children were assessed for disability. Ages of the
children assessed ranged from 1 to 14 years (mean 5 years)
and 59% were male. Assessments occurred on average 13
months after discharge from hospital (range 4—24 months).
Each assessment took approximately 35—40 minutes, includ-
ing the interview and observation components. Character-
istics of the cases assessed and other interview details are
presented in Table 3.
Disability assessment findings
Sixteen children (25%) had severe sequelae (lowest score
= 2), indicating their function was impaired enough to likely
make them dependent. Five (7%) had moderate sequelae,
mildly impairing function but probably compatible with inde-
pendent living. Twelve (18%) had minor sequelae with mild
effects on function or changes in behavior, and the remaining
16 children (25%) were considered to have recovered fully
(Figure 1).
Figure 1 Outcome of Japanese encephalitis infection in chil-
dren (N = 65; seven children lost to follow-up are not included in
the total).
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quently scored poorly on multiple assessment questions.
Almost one-third (5/16) of these children scored very poorly
in 10 or more of the 15 assessment items. Assessors often
noted the very serious condition of the children in this group.
Several children were noted to be totally incapacitated,
including one child in a vegetative state. Other sequelae
recorded included aphasia, deafness, frequent seizures, and
incontinence.
Children under 5 years of age were more likely to have
been scored as having severe sequelae compared to older
children, although this difference was only marginally sta-
tistically significant (43% vs. 16%, respectively; p = 0.06). A
higher percentage of males were scored as having severe
disability compared to females, but this was not statistically
significant (38% vs. 25%, respectively; p = 0.4).
The most common sequela overall was some type of beha-
vioral problem. More than half of the children assessed for
disability (26/49) were considered to have altered behavior
after illness. Five children were reported to get angry more
easily or to be more irritable or aggressive than before illness.
Other behavioral problems noted included crying or laughing
without reason or having become socially withdrawn.
Comparison of disability outcome assessed at
discharge and follow-up
Eight children included in the follow-up study also had been
assessed at discharge from hospital. These children ranged in
age from 1 to 8 years. The interval between their discharge
and follow-up assessments was on average 6 months (range
4—8 months). When their disability scores at discharge and
follow-up were compared, three children were assessed as
having the same level of disability (severe sequelae), four
children had improved, and one had deteriorated. Of the four
who had improved, three improved from severe to moderateor minor sequelae, and one with minor sequelae had recov-
ered fully. One child assessed as having mild sequelae at
discharge was assessed with severe sequelae 5 months later,
with deterioration in ability to stand, walk and feed.
Discussion
The results of this assessment demonstrate the serious
impact of JE. Half of the children who suffered JE either
died or were left with disabilities that were sufficiently
severe to result in the child being unlikely to lead an inde-
pendent life. Only one-quarter of the children were consid-
ered to have recovered to normal.
The study has some limitations that may affect the results
or their interpretation. Responses to subjective questions
could possibly have been influenced by the parent/care-
giver’s knowledge that their child had had a serious neuro-
logical illness. Conversely, a parent not wishing to disclose
any abnormality in their child, particularly if it could be a
source of discrimination, may not have reported specific
sequelae. Different responses could potentially occur based
on the perceptiveness of the individual interviewed or how
closely they interacted with the child. For this study, the
mother participated in the interview in the majority of cases,
which would have aided consistency. Additionally, one-third
of the assessment is based on objective observations.
Another limitation is that children were assessed at dif-
ferent time points. While a single time point after illness
would be ideal, this was not possible for logistical reasons. A
previous study demonstrated that most changes in condition
(improvement or deterioration) occur soon after hospital
discharge, and 75% of patients assessed at 3—6 months have
an identical grading if assessed again at a later time.12 All
children in this study were assessed at least 4 months after
discharge.
Estimates of the extent of disability following JE have
differed from country to country and in different studies
based on multiple factors, including the methodology used
for the assessment, the age group, and the type of patient
group examined (e.g., patients discharged from an urban
tertiary care facility or a rural hospital). Nevertheless, data
have consistently shown, as in this study, that there is a
significant burden from JE disability and mortality, as well as
a wide spectrum of sequelae including physical, intellectual,
and psychological problems.5,10,12,14
This study determined that five children had died after
discharge fromhospital.While thecauses ofdeathcouldnotbe
ascertained, the fact that most died at home and within
months of discharge strongly suggests these deaths were
related to, or a consequence of, JE. If so, it would imply that
children who survive acute JE illness have about a 10% chance
of death within the first few months after discharge. Deaths
after discharge from hospital have been noted in other
research studies.10,12,14 However, in reporting of routine JE
surveillance mortality data, many countries do not include
these deaths; information onpatient outcome is only available
at thepoint of discharge fromhospital. It is likely that reported
JE mortality rates based on routine disease surveillance data
underestimate overall mortality as a result of JE.
Follow-up of children after JE illness is often difficult.
Children living in rural areas are at highest risk of disease,
as exposure to rice field-breeding Culex tritaeniorhynchus
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longdistances fromhospitals. For several patients in this study,
for example, the visit to the patient’s home required a full
day’s travel for the hospital staff. However, to ensure best
outcomes for thechildren, follow-up is extremely important to
assess recovery, identify new problems that may develop, and
manage the rehabilitation process. In addition, routine doc-
umentation of the extent of disability after JE could be very
useful as part of disease surveillance programs conducted by
health departments, to help better understand the extent of
JE disease burden, and enable advocacy for support measures
for these children. The Liverpool Outcome Score could be a
helpful tool in this context, as it enables a simple, rapid
assessment of level of disability and the likelihood of inde-
pendent living.
By quantifying the level of disability and mortality after
JE in Indonesian children, this study contributes to a more
comprehensive understanding of disease burden, comple-
menting other epidemiological information collected on JE
disease in Indonesia. Although the number of JE cases that
occur may be fewer than some other diseases of public
health importance in the country, the severity of outcomes
demonstrates that the impact of JE is significant. Immu-
nization is recognized as the best way to control JE.15 The
results of this study provide useful data on the potential
impact of a JE immunization program, which could prevent
some of the economic and social burden of JE disease in
Indonesia.
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